Trinity Health IHA Medical Group Hematology Oncology-Brighton — Brighton, Michigan

Trinity Health IHA Medical Group Hematology Oncology-Brighton is a clinical research site located in Brighton, Michigan, United States 48114.

Crixeo Clinical Trials Trust Score: 35/100 (FAILING). This profile has not yet been claimed by the site owner.

Trinity Health IHA Medical Group Hematology Oncology-Brighton has participated in 212 clinical trials with 179 currently active.

Therapeutic areas: Metastatic Lung Non-Squamous Non-Small Cell Carcinoma, Recurrent Lung Non-Squamous Non-Small Cell Carcinoma, Stage IV Lung Non-Small Cell Cancer AJCC v7.

Sponsors: National Cancer Institute (NCI), Alliance for Clinical Trials in Oncology, ECOG-ACRIN Cancer Research Group.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Brighton

Browse all research sites in Michigan · View every site in Brighton

• University of Michigan Health System
• Saint Joseph Mercy Hospital - Brighton
• University of Michigan / Brighton Health Center
• University of Michigan Brighton Center for Specialty Care
• University of Michigan
• University of Michigan (Michigan Medicine)-Brighton Health Center
• Trinity Health Medical Center-Brighton
• Saint Joseph Mercy Brighton
• IHA Hematology Oncology Consultants-Brighton
• Brighton Center for Specialty Care
• Michigan Arthritis Research Center

Sponsor Feasibility Report

Trust Score: 35/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Trinity Health IHA Medical Group Hematology Oncology-Brighton?

Trinity Health IHA Medical Group Hematology Oncology-Brighton has a Crixeo Trust Score of 35/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Trinity Health IHA Medical Group Hematology Oncology-Brighton conducted?

Trinity Health IHA Medical Group Hematology Oncology-Brighton has 212 clinical trials on record, with 179 currently active. Their work covers Metastatic Lung Non-Squamous Non-Small Cell Carcinoma, Recurrent Lung Non-Squamous Non-Small Cell Carcinoma, Stage IV Lung Non-Small Cell Cancer AJCC v7.

Is Trinity Health IHA Medical Group Hematology Oncology-Brighton accredited by Crixeo Clinical Trials?

Trinity Health IHA Medical Group Hematology Oncology-Brighton has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Trinity Health IHA Medical Group Hematology Oncology-Brighton?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.